SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-053283
Filing Date
2012-11-15
Accepted
2012-11-15 16:48:38
Documents
1
Period of Report
2012-11-13

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c30447_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c30447_4x0.xml 4 6856
  Complete submission text file 0001209191-12-053283.txt   8305
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O HYBRIDON, INC. 345 VASSAR ST CAMBRIDGE MA 02139
Business Address
AGRAWAL SUDHIR (Reporting) CIK: 0001085605 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 121209282